Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

Clinical trial NCT04962958 · COMPLETED

Trial details

NCT number: NCT04962958
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma Carcinoma, Hepatocellular Liver Neoplasms Digestive System Neoplasms Antineoplastic Agents Donafenib Fluorouracil Oxaliplatin Antimetabolites

Start date: 2021-12-27
Primary completion: 2025-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.